Head-to-head · The Match Score
Ro vs Vaylen
Both scored on the same six-factor Match Score. Ro wins this matchup with a 85 to 81 edge.
Ro
#4 · Grade B
Patients who want a big, brand-name-capable platform and insurance navigation.
Visit RoVaylen
#18 · Grade B−
People who want maximum options — injectable, oral, compounded or brand — in one LegitScript-certified place.
Visit VaylenFactor by factor
The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.
Price, coverage & formulary
| Detail | Ro | Vaylen |
|---|---|---|
| Semaglutide | Not disclosed | $244/mo |
| Tirzepatide | Not disclosed | $325/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
| Match Score | 85 · B | 81 · B− |
Ro edges out Vaylen, 85 to 81 on the default Match Score. A heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.
Vaylen is still a fair pick if its strengths line up with yours — best for: People who want maximum options — injectable, oral, compounded or brand — in one LegitScript-certified place.
Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.
Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.
More head-to-heads
Or browse alternatives to Ro and all comparisons.
Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.